FDA proposes master control trial guidance that goes beyond COVID-19
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States